The same is true of any public corporation. The problem is that investors enforce perverse incentives through their own simple objectives. Investors don't care about how the money is made, so long as it's made; and the executives do anything in their power to meet that goal, provided the consequences are cheap enough to justify the move.
I think we need to force ISPs and utilities (and a few others, like pharma) to reincorporate as public-benefit corporations, so that profits aren't the sole driving factor in business decisions.
They probably didn't even know until after the fact.
There's some evidence of a disconnect between Hasbro and their legal team. They've sent C&Ds to several fan projects, including JanAnimations' "Button's Adventures" project, and it happened entirely without the knowledge of Hasbro's community outreach and executives, and as far as anyone knows, the issue with JanAnimations is still unresolved (though some of his videos are back up).
There's also the matter of Legends of Equestria, a fan-made MMO that's a blatant copy of the show's content. The only reason they haven't gotten a C&D (as far as anyone knows) is because they don't use the official names for anything except Equestria itself. This is another opportunity for Hasbro to enable some kind of licensing, but they've been silent on it.
The people at Hasbro and the studio responsible for My Little Pony; Friendship is Magic have had, for quite a while, a friendly, amicable relationship. Hasbro has been very excited about the massive quantity of creative work coming out of the Brony community (videos, music, fan art, stories, even fan-created episodes like Double Rainboom and Snowdrop, among others). In fact, they've said that the reason they made the movie Equestria Girls was specifically because of the prolific "humanized pony" fan art going around.
It's been a great thing all around for both the fan community and for Hasbro's bottom line.
And then Hasbro's legal team sent a Cease & Desist to JanAnimations over his extremely popular Adventures of Button Mash, which uses a character from the show (one who appears for less than 4 seconds in each of only two episodes.) Worst of all, no one at Hasbro even knew about the C&D letter until someone asked them about it.
Hasbro has since been in talks with JanAnimations about letting him revive the Button Mash work he'd started.
And then Hasbro's legal team sent a C&D to the creators of the also very popular Mentally Advanced series.
Given circumstances like this, I sincerely doubt that Konami and its legal department have even ever communicated about Philanthropy.
These corporate legal teams don't know or care about the secondary effects of fan works. All they see is possible trademark dilution or Copyright infringement.
If the analysts they hire are really so lacking in integrity that a few weeks without pay will make them turncoat traitors, why were they hired in the first place? Why didn't their high-security background check flag them as potential turncoats?
Oh, right, this is the NSA we're talking about. They're traitors to begin with.
GetPRSM.com isn't even trying to be subtle: Among the meta keywords are "Utah Datacenter" and "Parody." If you try to sign up, it pops up a dialog that says there are "technical problems" and links you to "technical support" over at the EFF website.
It even says "Made with love at Fort Meade" at the bottom and uses one of the famous pictures of the Utah datacenter.
This tells me we need to change the drug approval process.
Clearly, the FDA is at fault for a lot of this, and the Patent Office is clearly at fault for allowing the patent to be extended in this way.
What needs to happen, in my mind, is that the structure of the approval process needs to be inverted a little: When a pharma comes to the FDA with a new drug, making claims that it improves over another drug, then the FDA should have the resources from its own budget to perform the study and evaluation for efficacy, safety, etc., and then if the drug doesn't meet expectations, then the pharma should pay a fine for wasting the FDA's time, in addition to getting the approval denied.
In this way, the impetus is less on producing more drugs to extend patents and massive earnings and more on making more efficacious and safer drugs.
Getting rid of the shareholders' opinions in this matter would also be of great benefit.